Works matching AU Shiota, Masaki

Results: 152

Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.

Published in:

2016

By:

Masaki Shiota;
Naohiro Fujimoto;
Kenjiro Imada;
Akira Yokomizo;
Momoe Itsumi;
Ario Takeuchi;
Hidetoshi Kuruma;
Junichi Inokuchi;
Katsunori Tatsugami;
Takeshi Uchiumi;
Yoshinao Oda;
Seiji Naito;
Shiota, Masaki;
Fujimoto, Naohiro;
Imada, Kenjiro;
Yokomizo, Akira;
Itsumi, Momoe;
Takeuchi, Ario;
Kuruma, Hidetoshi;
Inokuchi, Junichi

Publication type:

journal article

Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 1, p. 89, doi. 10.1007/s00228-022-03420-0

By:

Takahashi, Yoshiko;
Narita, Shintaro;
Shiota, Masaki;
Miura, Masatomo;
Kagaya, Hideaki;
Kashima, Soki;
Yamamoto, Ryohei;
Nara, Taketoshi;
Huang, Mingguo;
Numakura, Kazuyuki;
Saito, Mitsuru;
Eto, Masatoshi;
Habuchi, Tomonori

Publication type:

Article

KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 225, doi. 10.3390/jcm8020225

By:

Sekino, Yohei;
Oue, Naohide;
Koike, Yuki;
Shigematsu, Yoshinori;
Sakamoto, Naoya;
Sentani, Kazuhiro;
Teishima, Jun;
Shiota, Masaki;
Matsubara, Akio;
Yasui, Wataru

Publication type:

Article

Clinical factors affecting perioperative outcomes in robot-assisted radical prostatectomy.

Published in:

Molecular & Clinical Oncology, 2018, v. 9, n. 5, p. 575, doi. 10.3892/mco.2018.1718

By:

Murakami, Tomohiko;
Otsubo, Satoshi;
Namitome, Ryo;
Shiota, Masaki;
Inokuchi, Junichi;
Takeuchi, Ario;
Kashiwagi, Eiji;
Tatsugami, Katsunori;
Eto, Masatoshi

Publication type:

Article

A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.

Published in:

Molecular & Clinical Oncology, 2018, v. 8, n. 6, p. 785, doi. 10.3892/mco.2018.1602

By:

Akitake, Masakazu;
Kiyoshima, Keijiro;
Yokomizo, Akira;
Shiga, Kenichiro;
Koga, Hirofumi;
Takeuchi, Ario;
Shiota, Masaki;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Yamaguchi, Akito;
Eto, Masatoshi

Publication type:

Article

Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study.

Published in:

Japanese Journal of Clinical Oncology, 2024, v. 54, n. 9, p. 1045, doi. 10.1093/jjco/hyae079

By:

Kawai, Taketo;
Onozawa, Mizuki;
Taguchi, Satoru;
Shiota, Masaki;
Sakamoto, Shinichi;
Yamamoto, Yoshiyuki;
Kitagawa, Yasuhide;
Nakagawa, Tohru;
Hinotsu, Shiro;
Kume, Haruki;
(J-CaP), Japan Study Group of Prostate Cancer

Publication type:

Article

Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer.

Published in:

Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 633, doi. 10.1093/jjco/hyac035

By:

Terada, Naoki;
Aizawa, Rihito;
Nihei, Keiji;
Shiota, Masaki;
Kojima, Takahiro;
Kimura, Takahiro;
Inoue, Takahiro;
Kitamura, Hiroshi;
Sugimoto, Mikio;
Nishiyama, Hiroyuki;
Mizowaki, Takashi;
Kamoto, Toshiyuki

Publication type:

Article

Prognostic impact of prior local therapy in castration-resistant prostate cancer.

Published in:

Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1142, doi. 10.1093/jjco/hyab019

By:

Koura, Mikifumi;
Shiota, Masaki;
Ueda, Shohei;
Matsumoto, Takashi;
Kobayashi, Satoshi;
Monji, Keisuke;
Kashiwagi, Eiji;
Takeuchi, Ario;
Inokuchi, Junichi;
Shiga, Ken-ichiro;
Yokomizo, Akira;
Eto, Masatoshi

Publication type:

Article

Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: From "All-Comers" to "Personalized" Approach.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 2967, doi. 10.2147/OTT.S306345

By:

Harada, Kenichi;
Shiota, Masaki;
Minato, Akinori;
Matsumoto, Masahiro;
Tomisaki, Ikko;
Fujisawa, Masato;
Fujimoto, Naohiro

Publication type:

Article

Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus Nivolumab.

Published in:

Clinical Genitourinary Cancer, 2024, v. 22, n. 1, p. e122, doi. 10.1016/j.clgc.2023.09.003

By:

Leandro Blas;
Masaki Shiota;
Shigehiro Tsukahara;
Shohei Nagakawa;
Takashi Matsumoto;
Masatoshi Eto

Publication type:

Article

A Phase II Trial of Abiraterone With Dutasteride for Second‐Generation Antiandrogen‐ and Chemotherapy‐Naïve Patients With Castration‐Resistant Prostate Cancer.

Published in:

Journal of Clinical Pharmacology, 2023, v. 63, n. 4, p. 445, doi. 10.1002/jcph.2191

By:

Shiota, Masaki;
Inoue, Ryo;
Tashiro, Kojiro;
Kobayashi, Keita;
Horiyama, Shizuyo;
Kanji, Hiromi;
Eto, Masatoshi;
Egawa, Shin;
Haginaka, Jun;
Matsuyama, Hideyasu

Publication type:

Article

Villous adenoma of female urethra: An investigation of the mechanism of development regarding glandular neoplasms in the urinary tract.

Published in:

Indian Journal of Urology, 2006, v. 22, n. 4, p. 376, doi. 10.4103/0970-1591.29132

By:

Shiota, Masaki;
Tokuda, Noriaki;
Kanou, Takehiro;
Yamasaki, Humio

Publication type:

Article

The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy.

Published in:

Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 3, p. 495, doi. 10.1007/s00432-014-1828-7

By:

Shiota, Masaki;
Yokomizo, Akira;
Takeuchi, Ario;
Imada, Kenjiro;
Kiyoshima, Keijiro;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Naito, Seiji

Publication type:

Article

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1903, doi. 10.1007/s00262-023-03367-w

By:

Shiota, Masaki;
Miyake, Hideaki;
Takahashi, Masayuki;
Oya, Mototsugu;
Tsuchiya, Norihiko;
Masumori, Naoya;
Matsuyama, Hideyasu;
Obara, Wataru;
Shinohara, Nobuo;
Fujimoto, Kiyohide;
Nozawa, Masahiro;
Ohba, Kojiro;
Ohyama, Chikara;
Hashine, Katsuyoshi;
Akamatsu, Shusuke;
Kamba, Tomomi;
Mita, Koji;
Gotoh, Momokazu;
Tatarano, Shuichi;
Fujisawa, Masato

Publication type:

Article

Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 727, doi. 10.1007/s00262-021-03032-0

By:

Kobayashi, Mizuki;
Fujiyama, Nobuhiro;
Tanegashima, Tokiyoshi;
Narita, Shintaro;
Yamamoto, Yoshiaki;
Fujimoto, Naohiro;
Ueda, Shohei;
Takeuchi, Ario;
Numakura, Kazuyuki;
Habuchi, Tomonori;
Matsuyama, Hideyasu;
Eto, Masatoshi;
Shiota, Masaki

Publication type:

Article

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1155, doi. 10.1007/s00262-020-02533-8

By:

Shiota, Masaki;
Fujimoto, Naohiro;
Yamamoto, Yoshiaki;
Takeuchi, Ario;
Tatsugami, Katsunori;
Uchiumi, Takeshi;
Matsuyama, Hideyasu;
Eto, Masatoshi

Publication type:

Article

YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 517, doi. 10.1007/s00262-012-1356-8

By:

Takeuchi, Ario;
Shiota, Masaki;
Tatsugami, Katsunori;
Yokomizo, Akira;
Kuroiwa, Kentaro;
Dejima, Takashi;
Tanaka, Shingo;
Itsumi, Momoe;
Eto, Masatoshi;
Naito, Seiji

Publication type:

Article

X‐ray structure of the direct electron transfer‐type FAD glucose dehydrogenase catalytic subunit complexed with a hitchhiker protein.

Published in:

Acta Crystallographica: Section D, Structural Biology, 2019, v. 75, n. 9, p. 841, doi. 10.1107/S2059798319010878

By:

Yoshida, Hiromi;
Kojima, Katsuhiro;
Shiota, Masaki;
Yoshimatsu, Keiichi;
Yamazaki, Tomohiko;
Ferri, Stefano;
Tsugawa, Wakako;
Kamitori, Shigehiro;
Sode, Koji

Publication type:

Article

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12528-3

By:

Tsukahara, Shigehiro;
Shiota, Masaki;
Takamatsu, Dai;
Nagakawa, Shohei;
Matsumoto, Takashi;
Kiyokoba, Ryo;
Yagi, Mikako;
Setoyama, Daiki;
Noda, Nozomi;
Matsumoto, Shinya;
Hayashi, Tetsutaro;
Contreras-Sanz, Alberto;
Black, Peter C.;
Inokuchi, Junichi;
Kohashi, Kenichi;
Oda, Yoshinao;
Uchiumi, Takeshi;
Eto, Masatoshi;
Kang, Dongchon

Publication type:

Article

The Role of Nuclear Receptors in Prostate Cancer.

Published in:

Cells (2073-4409), 2019, v. 8, n. 6, p. 602, doi. 10.3390/cells8060602

By:

Shiota, Masaki;
Fujimoto, Naohiro;
Kashiwagi, Eiji;
Eto, Masatoshi

Publication type:

Article

The significance of strong histone deacetylase 1 expression in the progression of prostate cancer.

Published in:

Histopathology, 2011, v. 58, n. 5, p. 773, doi. 10.1111/j.1365-2559.2011.03797.x

By:

YooHyun Song;
Shiota, Masaki;
Tamiya, Sadafumi;
Kuroiwa, Kentaro;
Naito, Seiji;
Tsuneyoshi, Masazumi

Publication type:

Article

Field experiment of a telesurgery system using a surgical robot with haptic feedback.

Published in:

Surgery Today, 2024, v. 54, n. 4, p. 375, doi. 10.1007/s00595-023-02732-7

By:

Ota, Mitsuhiko;
Oki, Eiji;
Nakanoko, Tomonori;
Tanaka, Yasushi;
Toyota, Satoshi;
Hu, Qingjiang;
Nakaji, Yu;
Nakanishi, Ryota;
Ando, Koji;
Kimura, Yasue;
Hisamatsu, Yuichi;
Mimori, Koshi;
Takahashi, Yoshiya;
Morohashi, Hajime;
Kanno, Takahiro;
Tadano, Kotaro;
Kawashima, Kenji;
Takano, Hironobu;
Ebihara, Yuma;
Shiota, Masaki

Publication type:

Article

The Omission of Upfront Treatment Intensification Does Not Adversely Affect Oncological Outcomes in a Subset of Castration-Highly Sensitive Metastatic Prostate Cancer.

Published in:

In Vivo, 2024, v. 38, n. 5, p. 2328, doi. 10.21873/invivo.13698

By:

NAOHIRO FUJIMOTO;
YUJIRO NAGATA;
MASAKI SHIOTA;
AKINORI MINATO;
IKKO TOMISAKI;
KENICHI HARADA;
HIROSHI MIYAMOTO

Publication type:

Article

Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer.

Published in:

In Vivo, 2021, v. 35, n. 2, p. 1101, doi. 10.21873/invivo.12355

By:

NAOHIRO FUJIMOTO;
MASAKI SHIOTA;
TAKUO MATSUKAWA;
AKINORI MINATO;
IKKO TOMISAKI;
REI OHNISHI;
MASATOSHI ETO

Publication type:

Article

Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare.

Published in:

BJU International, 2016, v. 118, n. 6, p. 880, doi. 10.1111/bju.13483

By:

Shiota, Masaki;
Yokomizo, Akira;
Takeuchi, Ario;
Kiyoshima, Keijiro;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Shiga, Ken ‐ ichiro;
Koga, Hirofumi;
Yamaguchi, Akito;
Naito, Seiji;
Eto, Masatoshi

Publication type:

Article

Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.

Published in:

BJU International, 2011, v. 108, n. 2b, p. E142, doi. 10.1111/j.1464-410X.2010.09810.x

By:

Shiota, Masaki;
Yokomizo, Akira;
Itsumi, Momoe;
Uchiumi, Takeshi;
Tada, Yasuhiro;
Song, YooHyun;
Kashiwagi, Eiji;
Masubuchi, Daisuke;
Naito, Seiji

Publication type:

Article

Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin.

Published in:

BJU International, 2011, v. 107, n. 7, p. 1148, doi. 10.1111/j.1464-410X.2010.09535.x

By:

Shiota, Masaki;
Tsunoda, Toshiyuki;
YooHyun Song;
Yokomizo, Akira;
Tada, Yasuhiro;
Oda, Yoshinao;
Naito, Seiji

Publication type:

Article

IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation.

Published in:

BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10398-6

By:

Kato, Taigo;
Matsubara, Nobuaki;
Shiota, Masaki;
Eto, Masatoshi;
Osawa, Takahiro;
Abe, Takashige;
Shinohara, Nobuo;
Yasumizu, Yota;
Tanaka, Nobuyuki;
Oya, Mototsugu;
Nishimoto, Koshiro;
Hayashi, Takuji;
Nakayama, Masashi;
Kojima, Takahiro;
Namikawa, Kenjiro;
Fujisawa, Takao;
Okano, Susumu;
Hida, Eisuke;
Nakamura, Yoshiaki;
Bando, Hideaki

Publication type:

Article

Genetic variations predicting progression with docetaxel and novel androgen‐receptor pathway inhibitors.

Published in:

Cancer Science, 2023, v. 114, n. 4, p. 1625, doi. 10.1111/cas.15718

By:

Shiota, Masaki;
Akamatsu, Shusuke;
Sekine, Yuya;
Kimura, Hiroko;
Narita, Shintaro;
Fujimoto, Naohiro;
Terada, Naoki;
Blas, Leandro;
Habuchi, Tomonori;
Kamoto, Toshiyuki;
Momozawa, Yukihide;
Eto, Masatoshi

Publication type:

Article

Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients.

Published in:

Cancer Science, 2022, v. 113, n. 9, p. 3120, doi. 10.1111/cas.15438

By:

Igami, Ko;
Uchiumi, Takeshi;
Shiota, Masaki;
Ueda, Saori;
Tsukahara, Shigehiro;
Akimoto, Masaru;
Eto, Masatoshi;
Kang, Dongchon

Publication type:

Article

Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer.

Published in:

Cancer Science, 2022, v. 113, n. 7, p. 2386, doi. 10.1111/cas.15383

By:

Shiota, Masaki;
Takamatsu, Dai;
Kimura, Takahiro;
Tashiro, Kojiro;
Matsui, Yoshiyuki;
Tomida, Ryotaro;
Saito, Ryoichi;
Tsutsumi, Masakazu;
Yokomizo, Akira;
Yamamoto, Yoshiyuki;
Edamura, Kohei;
Miyake, Makito;
Morizane, Shuichi;
Yoshino, Takayuki;
Matsukawa, Akihiro;
Narita, Shintaro;
Matsumoto, Ryuji;
Kasahara, Takashi;
Hashimoto, Kohei;
Matsumoto, Hiroaki

Publication type:

Article

An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer.

Published in:

Cancer Science, 2022, v. 113, n. 5, p. 1731, doi. 10.1111/cas.15280

By:

Ushijima, Miho;
Shiota, Masaki;
Matsumoto, Takashi;
Kashiwagi, Eiji;
Inokuchi, Junichi;
Eto, Masatoshi

Publication type:

Article

Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer.

Published in:

Cancer Science, 2021, v. 112, n. 9, p. 3616, doi. 10.1111/cas.15038

By:

Shiota, Masaki;
Terada, Naoki;
Kitamura, Hiroshi;
Kojima, Takahiro;
Saito, Toshihiro;
Yokomizo, Akira;
Kohei, Naoki;
Goto, Takayuki;
Kawamura, Sadafumi;
Hashimoto, Yasuhiro;
Takahashi, Atsushi;
Kimura, Takahiro;
Tabata, Ken‐ichi;
Tomida, Ryotaro;
Hashimoto, Kohei;
Sakurai, Toshihiko;
Shimazui, Toru;
Sakamoto, Shinichi;
Kamiyama, Manabu;
Tanaka, Nobumichi

Publication type:

Article

Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old.

Published in:

Cancer Science, 2021, v. 112, n. 8, p. 3074, doi. 10.1111/cas.14974

By:

Blas, Leandro;
Onozawa, Mizuki;
Shiota, Masaki;
Hinotsu, Shiro;
Sakamoto, Shinichi;
Kitagawa, Yasuhide;
Kawai, Taketo;
Eto, Masatoshi;
Kume, Haruki;
Akaza, Hideyuki

Publication type:

Article

Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients.

Published in:

Cancer Science, 2021, v. 112, n. 4, p. 1524, doi. 10.1111/cas.14722

By:

Shiota, Masaki;
Terada, Naoki;
Saito, Toshihiro;
Yokomizo, Akira;
Kohei, Naoki;
Goto, Takayuki;
Kawamura, Sadafumi;
Hashimoto, Yasuhiro;
Takahashi, Atsushi;
Kimura, Takahiro;
Tabata, Ken‐ichi;
Tomida, Ryotaro;
Hashimoto, Kohei;
Sakurai, Toshihiko;
Shimazui, Toru;
Sakamoto, Shinichi;
Kamiyama, Manabu;
Tanaka, Nobumichi;
Mitsuzuka, Koji;
Kato, Takuma

Publication type:

Article

Gene amplification of YB‐1 in castration‐resistant prostate cancer in association with aberrant androgen receptor expression.

Published in:

Cancer Science, 2021, v. 112, n. 1, p. 323, doi. 10.1111/cas.14695

By:

Shiota, Masaki;
Sekino, Yohei;
Tsukahara, Shigehiro;
Abe, Tatsuro;
Kinoshita, Fumio;
Imada, Kenjiro;
Ueda, Shohei;
Ushijima, Miho;
Nagakawa, Shohei;
Matsumoto, Takashi;
Kashiwagi, Eiji;
Takeuchi, Ario;
Inokuchi, Junichi;
Uchiumi, Takeshi;
Oda, Yoshinao;
Eto, Masatoshi

Publication type:

Article

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants.

Published in:

Cancer Science, 2018, v. 109, n. 10, p. 3224, doi. 10.1111/cas.13751

By:

Shiota, Masaki;
Dejima, Takashi;
Yamamoto, Yoshiaki;
Takeuchi, Ario;
Imada, Kenjiro;
Kashiwagi, Eiji;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Kajioka, Shunichi;
Uchiumi, Takeshi;
Eto, Masatoshi

Publication type:

Article

Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2.

Published in:

Cancer Science, 2016, v. 107, n. 7, p. 1022, doi. 10.1111/cas.12948

By:

Itsumi, Momoe;
Shiota, Masaki;
Takeuchi, Ario;
Kashiwagi, Eiji;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Kajioka, Shunichi;
Uchiumi, Takeshi;
Naito, Seiji;
Eto, Masatoshi;
Yokomizo, Akira

Publication type:

Article

P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance.

Published in:

Cancer Science, 2010, v. 101, n. 8, p. 1797, doi. 10.1111/j.1349-7006.2010.01598.x

By:

Shiota, Masaki;
Yokomizo, Akira;
Tada, Yasuhiro;
Uchiumi, Takeshi;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Kuroiwa, Kentaro;
Yamamoto, Ken;
Seki, Narihito;
Naito, Seiji

Publication type:

Article

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin.

Published in:

Cancer Science, 2010, v. 101, n. 5, p. 1177, doi. 10.1111/j.1349-7006.2010.01503.x

By:

Shiota, Masaki;
Yokomizo, Akira;
Kashiwagi, Eiji;
Tada, Yasuhiro;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Kuroiwa, Kentaro;
Uchiumi, Takeshi;
Seki, Narihito;
Naito, Seiji

Publication type:

Article

Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1.

Published in:

Cancer Science, 2008, v. 99, n. 10, p. 1950, doi. 10.1111/j.1349-7006.2008.00912.x

By:

Shiota, Masaki;
Izumi, Hiroto;
Miyamoto, Naoya;
Onitsuka, Takamitsu;
Kashiwagi, Eiji;
Kidani, Akihiko;
Hirano, General;
Takahashi, Mayu;
Ono, Mayumi;
Kuwano, Michihiko;
Naito, Seiji;
Sasaguri, Yasuyuki;
Kohno, Kimitoshi

Publication type:

Article

DNA topoisomerase inhibitor, etoposide, enhances GC-box-dependent promoter activity via Sp1 phosphorylation.

Published in:

Cancer Science, 2007, v. 98, n. 6, p. 858, doi. 10.1111/j.1349-7006.2007.00476.x

By:

Niina, Ichiro;
Uchiumi, Takeshi;
Izumi, Hiroto;
Torigoe, Takayuki;
Wakasugi, Tetsuro;
Igarashi, Tomonori;
Miyamoto, Naoya;
Onitsuka, Takamitsu;
Shiota, Masaki;
Okayasu, Ryuichi;
Chijiiwa, Kazuo;
Kohno, Kimitoshi

Publication type:

Article

Regression and growth rates in androgen deprivation therapy for advanced castration-sensitive prostate cancer.

Published in:

World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05316-3

By:

Blas, Leandro;
Shiota, Masaki;
Matsuyama, Hideyasu;
Kamoto, Toshiyuki;
Enokida, Hideki;
Fujimoto, Naohiro;
Sakai, Hideki;
Igawa, Tsukasa;
Kamba, Tomomi;
Yokomizo, Akira;
Naito, Seiji;
Eto, Masatoshi

Publication type:

Article

Prediction of undetectable circulating tumor DNA by comprehensive genomic profiling assay in metastatic prostate cancer: the SCRUM-Japan MONSTAR SCREEN project.

Published in:

World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05240-6

By:

Shiota, Masaki;
Matsubara, Nobuaki;
Kato, Taigo;
Eto, Masatoshi;
Osawa, Takahiro;
Abe, Takashige;
Shinohara, Nobuo;
Nishimoto, Koshiro;
Yasumizu, Yota;
Tanaka, Nobuyuki;
Oya, Mototsugu;
Fujisawa, Takao;
Horasawa, Satoshi;
Nakamura, Yoshiaki;
Yoshino, Takayuki;
Nonomura, Norio

Publication type:

Article

Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.

Published in:

World Journal of Urology, 2023, v. 41, n. 1, p. 43, doi. 10.1007/s00345-022-04245-3

By:

Blas, Leandro;
Shiota, Masaki;
Takamatsu, Dai;
Kinoshita, Fumio;
Matsumoto, Takashi;
Lee, Ken;
Monji, Keisuke;
Kashiwagi, Eiji;
Inokuchi, Junichi;
Eto, Masatoshi

Publication type:

Article

Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate.

Published in:

World Journal of Urology, 2015, v. 33, n. 3, p. 329, doi. 10.1007/s00345-014-1310-9

By:

Otsubo, Satoshi;
Yokomizo, Akira;
Mochida, Osamu;
Shiota, Masaki;
Tatsugami, Katsunori;
Inokuchi, Junich;
Naito, Seiji

Publication type:

Article

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study.

Published in:

2019

By:

Shiota, Masaki;
Nakamura, Motonobu;
Yokomizo, Akira;
Tomoda, Toshihisa;
Sakamoto, Naotaka;
Seki, Narihito;
Hasegawa, Shuji;
Yunoki, Takakazu;
Harano, Masahiko;
Kuroiwa, Kentaro;
Eto, Masatoshi

Publication type:

journal article

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men.

Published in:

2019

By:

Shiota, Masaki;
Fujimoto, Naohiro;
Tsukahara, Shigehiro;
Ushijima, Miho;
Takeuchi, Ario;
Kashiwagi, Eiji;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Uchiumi, Takeshi;
Eto, Masatoshi

Publication type:

journal article

Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1557, doi. 10.1007/s00280-011-1660-6

By:

Takeuchi, Ario;
Shiota, Masaki;
Tatsugami, Katsunori;
Yokomizo, Akira;
Eto, Masatoshi;
Inokuchi, Junichi;
Kuroiwa, Kentaro;
Kiyoshima, Keijiro;
Naito, Seiji

Publication type:

Article

Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.

Published in:

Cancer Investigation, 2021, v. 39, n. 3, p. 251, doi. 10.1080/07357907.2020.1871486

By:

Yamashita, Takuya;
Shiota, Masaki;
Machidori, Asako;
Kobayashi, Satoshi;
Matsumoto, Takashi;
Monji, Keisuke;
Kashiwagi, Eiji;
Takeuchi, Ario;
Takahashi, Ryosuke;
Inokuchi, Junichi;
Shiga, Ken-ichiro;
Yokomizo, Akira;
Eto, Masatoshi

Publication type:

Article